Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net Revenue 1 by 22% to Record $42.7 million, with leadership positions across key markets Delivers Adjusted […]
Tag: Aurora Cannabis Inc.
Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB, Oct. 22, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled […]
Aurora Cannabis Announces Supply Agreement with SNDL
NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB, February 6, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB) –the Canadian based […]
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results
NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical Cannabis Re-Affirms Target of Positive […]
Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB, Oct. 24, 2024 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today announced today that […]













